• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National Cardiovascular Data Registry).

作者信息

Krone Ronald J, Shaw Richard E, Klein Lloyd W, Block Peter C, Anderson H Vernon, Weintraub William S, Brindis Ralph G, McKay Charles R

机构信息

Department of Medicine, Washington University, St. Louis, Missouri, USA.

出版信息

Am J Cardiol. 2003 Aug 15;92(4):389-94. doi: 10.1016/s0002-9149(03)00655-6.

DOI:10.1016/s0002-9149(03)00655-6
PMID:12914867
Abstract

In 1988 American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines for Coronary Angioplasty proposed a lesion classification system to stratify lesions by difficulty and risk to better understand the outcomes of coronary interventions. It was a 3-level (A, B, and C) classification based on 11 lesion characteristics. A modification, dividing the intermediate B category into B1 and B2, is also in common use. Recently, a simplification of this classification was evaluated using the large Society for Cardiac Angiography and Interventions (SCAI) Registry (SCAI I = non-C/patent; SCAI II = C/patent; SCAI III = non-C/occluded; SCAI IV = C/occluded). The lesion classification systems were evaluated in 61,926 patients from the ACC National Cardiovascular Data Registry who underwent single-vessel percutaneous coronary intervention between January 1998 and September 2000. Stents were placed in 74.5% of patients. Logistic models for lesion success and complications were constructed and compared. The c statistic for success using the ACC/AHA original classification system was 0.69, 0.71 for the modified ACC/AHA system, and 0.75 for the SCAI classification. The range of complication and success rates was greater using the SCAI models, and the logistic models for success and complication were more robust for the SCAI system. Thus, in the large ACC-National Cardiovascular Data Registry, with a high percentage of stent usage, the simpler SCAI lesion classification provided better discrimination for success and complications than the more complex ACC/AHA lesion classification system-original or modified.

摘要

相似文献

1
Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National Cardiovascular Data Registry).
Am J Cardiol. 2003 Aug 15;92(4):389-94. doi: 10.1016/s0002-9149(03)00655-6.
2
A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention.一种用于预测冠状动脉血管成形术成功率和并发症的简化病变分类。心脏血管造影和介入学会注册委员会。
Am J Cardiol. 2000 May 15;85(10):1179-84. doi: 10.1016/s0002-9149(00)00724-4.
3
Evaluation of the Society for Coronary Angiography and Interventions' lesion classification system in 14,133 patients with percutaneous coronary interventions in the current stent era.在当前支架时代,对14133例行经皮冠状动脉介入治疗患者应用冠状动脉造影和介入学会病变分类系统的评估。
Catheter Cardiovasc Interv. 2002 Jan;55(1):1-7. doi: 10.1002/ccd.10074.
4
Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions.梅奥诊所风险评分与美国心脏病学会/美国心脏协会病变分类在经皮冠状动脉介入治疗后不良心血管结局预测中的比较。
J Am Coll Cardiol. 2004 Jul 21;44(2):357-61. doi: 10.1016/j.jacc.2004.03.059.
5
[The classification of coronary lesion from Society for Cardiac Angiography and Intervention predicts better results of coronary angioplasty than the one from American College of Cardiology/American Heart Association Coronary Disease].[与美国心脏病学会/美国心脏协会冠状动脉疾病分类相比,心脏血管造影和介入学会的冠状动脉病变分类能更好地预测冠状动脉血管成形术的结果]
Rev Med Chil. 2001 Jun;129(6):605-10.
6
Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s.20世纪90年代后期美国心脏病学会/美国心脏协会冠状动脉狭窄形态学分类在冠状动脉介入治疗中的价值。
Am J Cardiol. 1998 Jul 1;82(1):43-9. doi: 10.1016/s0002-9149(98)00239-2.
7
Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial.美国心脏病学会/美国心脏协会冠状动脉病变形态学血管造影分类在支架内再狭窄患者中的价值。来自支架内再狭窄球囊血管成形术与选择性支架置入术(RIBS)随机试验的见解。
Am Heart J. 2006 Mar;151(3):681.e1-681.e9. doi: 10.1016/j.ahj.2005.10.014.
8
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
Circulation. 1990 Oct;82(4):1193-202. doi: 10.1161/01.cir.82.4.1193.
9
Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement.
Circulation. 1999 Sep 21;100(12):1285-90. doi: 10.1161/01.cir.100.12.1285.
10
2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2015年美国心脏病学会/美国心脏协会/心血管造影和介入学会关于ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗的重点更新:2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南及2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南的更新:美国心脏病学会/美国心脏协会临床实践指南工作组和心血管造影和介入学会的报告
Catheter Cardiovasc Interv. 2016 May;87(6):1001-19. doi: 10.1002/ccd.26325.

引用本文的文献

1
The clinical utility of circulating cell division control 42 in small-vessel coronary artery disease patients undergoing drug-coated balloon treatment.在接受药物涂层球囊治疗的小血管冠状动脉疾病患者中,循环细胞分裂控制蛋白 42 的临床应用价值。
BMC Cardiovasc Disord. 2023 Oct 7;23(1):496. doi: 10.1186/s12872-023-03476-5.
2
Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment.Xinsorb 支架相关参数对氯吡格雷治疗的单支初发冠状动脉病变患者血小板反应性的影响。
Anatol J Cardiol. 2023 Jul 3;27(7):408-416. doi: 10.14744/AnatolJCardiol.2023.3071. Epub 2023 Jun 7.
3
Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis.
评估澳大利亚维多利亚心脏结局注册研究的成本效益和投资回报:最小阈值分析。
BMJ Open. 2023 Apr 25;13(4):e066106. doi: 10.1136/bmjopen-2022-066106.
4
Estimating the economic impacts of percutaneous coronary intervention in Australia: a registry-based cost burden study.估算澳大利亚经皮冠状动脉介入治疗的经济影响:基于登记的费用负担研究。
BMJ Open. 2021 Dec 7;11(12):e053305. doi: 10.1136/bmjopen-2021-053305.
5
Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary Interventions.经皮机械循环支持装置在急性心肌梗死并发心源性休克及高危经皮冠状动脉介入治疗中的应用
J Clin Med. 2019 Aug 13;8(8):1209. doi: 10.3390/jcm8081209.
6
Steerable microcatheters for complex percutaneous coronary interventions in octogenarians: from Venture to Swift Ninja.用于老年患者复杂经皮冠状动脉介入治疗的可操纵微导管:从Venture到Swift Ninja
J Geriatr Cardiol. 2019 Jan;16(1):54-59. doi: 10.11909/j.issn.1671-5411.2019.01.004.
7
Analysis of traditional and emerging risk factors in premenopausal women with coronary artery disease: A pilot-scale study from North India.绝经前冠心病女性传统及新出现危险因素分析:来自印度北部的一项试点规模研究。
Mol Cell Biochem. 2017 Aug;432(1-2):67-78. doi: 10.1007/s11010-017-2998-9. Epub 2017 Mar 23.
8
Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study.一项观察性研究表明:无论围手术期心肌损伤情况如何,选择性经皮冠状动脉介入治疗都会导致血清抵抗素、瘦素和脂联素水平发生显著变化。
Anatol J Cardiol. 2016 Dec;16(12):940-946. doi: 10.14744/AnatolJCardiol.2016.6876. Epub 2016 Jun 29.
9
Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis.在无提示心肌坏死的临床及操作迹象的患者中,进行无并发症的择期经皮冠状动脉介入治疗后血清肌钙蛋白水平升高。
Postepy Kardiol Interwencyjnej. 2016;12(1):41-8. doi: 10.5114/pwki.2016.56948. Epub 2016 Feb 11.
10
German stereotaxis-guided percutaneous coronary intervention study group: first multicenter real world experience.德国立体定向引导经皮冠状动脉介入研究组:首个多中心真实世界经验。
Clin Res Cardiol. 2009 Sep;98(9):541-7. doi: 10.1007/s00392-009-0037-x. Epub 2009 Jun 12.